Tissue is an issue in the search for biomarkers in idiopathic pulmonary fibrosis

Fibrogenesis and Tissue Repair

Volumn 8, Issue 1, 2015, Pages

  Kaarteenaho, Riitta ^a,b,c,d   Lappi Blanco, Elisa ^b,e  

^a MEDICAL RESEARCH CENTER OULU   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Immunohistochemistry; Microarray; Proteomic; Transcriptomic; UIP; Usual interstitial pneumonia

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN 4; CD3 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CHYMASE; EOSINOPHIL PEROXIDASE; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 4; KI 67 ANTIGEN; LATENT MEMBRANE PROTEIN 1; MUCIN 5B; PROTEINASE ACTIVATED RECEPTOR 2; SERINE PROTEINASE INHIBITOR; SURFACTANT PROTEIN A; TELOMERASE; TENASCIN; TRANSFORMING GROWTH FACTOR BETA;

BLOOD ANALYSIS; CONNECTIVE TISSUE DISEASE; DIFFERENTIAL DIAGNOSIS; EXTRACELLULAR MATRIX; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; GENETIC POLYMORPHISM; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS EPITHELIUM; LUNG BIOPSY; LUNG DIFFUSION CAPACITY; LUNG DISEASE; LUNG LAVAGE; LUNG PARENCHYMA; NON INVASIVE MEASUREMENT; PATHOGENESIS; PROMOTER REGION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SPUTUM ANALYSIS; TRANSCRIPTOMICS;

EID: 84927920905     PISSN: None     EISSN: 17551536     Source Type: Journal    
DOI: 10.1186/s13069-015-0020-2     Document Type: Review

References (46)

1. Foundation for the National Institutes of Health. Biomarkers Consortium. www.fnih.org/work/key-initiatives/biomarkers-consortium..
2. Zhang Y, Kaminski N. Biomarkers in idiopathic pulmonary fibrosis. Curr Opin Pulm Med 2012, 18(5):441-6. 10.1097/MCP.0b013e328356d03c, 22847105.
3. Vij R, Noth I. Peripheral blood biomarkers in idiopathic pulmonary fibrosis. Transl Res 2012, 159(4):218-27. 10.1016/j.trsl.2012.01.012, 22424426.
4. Kaarteenaho R. The current position of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis. Respir Res. 2013, 14:43. 10.1186/1465-9921-14-43, 23587070.
5. Casoni GL, Tomassetti S, Cavazza A, Colby TV, Dubini A, Ryu JH, et al. Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases. PLoS One 2014, 9(2):e86716. 10.1371/journal.pone.0086716, 24586252.
6. Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 2011, 364(16):1503-12. 10.1056/NEJMoa1013660, 21506741.
7. Nicholson AG, Fulford LG, Colby TV, du Bois RM, Hansell DM, Wells AU. The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002, 166(2):173-7. 10.1164/rccm.2109039, 12119229.
8. Enomoto N, Suda T, Kato M, Kaida Y, Nakamura Y, Imokawa S, et al. Quantitative analysis of fibroblast foci in usual interstitial pneumonia. Chest 2006, 130(1):22-9. 10.1378/chest.130.1.22, 16840378.
9. King TE, Schwarz MI, Brown K, Tooze JA, Colby TV, Waldron JA, et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 2001, 164(6):1025-32. 10.1164/ajrccm.164.6.2001056, 11587991.
10. Lee SH, Shim HS, Cho SH, Kim SY, Lee SK, Son JY, et al. Prognostic factors for idiopathic pulmonary fibrosis: clinical, physiologic, pathologic, and molecular aspects. Sarcoidosis Vasc Diffuse Lung Dis 2011, 28(2):102-12. 22117501.
11. Tiitto L, Bloigu R, Heiskanen U, Pääkkö P, Kinnula VL, Kaarteenaho-Wiik R. Relationship between histopathological features and the course of idiopathic pulmonary fibrosis/usual interstitial pneumonia. Thorax 2006, 61(12):1091-5. 10.1136/thx.2005.055814, 16769713.
12. Flaherty KR, Colby TV, Travis WD, Toews GB, Mumford J, Murray S, et al. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 2003, 167(10):1410-5. 10.1164/rccm.200204-373OC, 12615630.
13. Park YS, Park CM, Lee HJ, Goo JM, Chung DH, Lee SM, et al. Clinical implication of protease-activated receptor-2 in idiopathic pulmonary fibrosis. Respir Med 2013, 107(2):256-62. 10.1016/j.rmed.2012.10.011, 23131707.
14. Tzouvelekis A, Ntolios P, Karameris A, Vilaras G, Boglou P, Koulelidis A, et al. Increased expression of epidermal growth factor receptor (EGF-R) in patients with different forms of lung fibrosis. Biomed Res Int. 2013, 2013:654354. 10.1155/2013/654354, 23841084.
15. Todd NW, Scheraga RG, Galvin JR, Iacono AT, Britt EJ, Luzina IG, et al. Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis. J Inflamm Res. 2013, 6:63-70. 10.2147/JIR.S40673, 23576879.
16. Waisberg DR, Parra ER, Barbas-Filho JV, Fernezlian S, Capelozzi VL. Increased fibroblast telomerase expression precedes myofibroblast α-smooth muscle actin expression in idiopathic pulmonary fibrosis. Clinics (Sao Paulo). 2012, 67(9):1039-46. 10.6061/clinics/2012(09)10, 23018301.
17. Calabrese F, Lunardi F, Balestro E, Marulli G, Perissinotto E, Loy M, et al. Serpin B4 isoform overexpression is associated with aberrant epithelial proliferation and lung cancer in idiopathic pulmonary fibrosis. Pathology 2012, 44(3):192-8. 10.1097/PAT.0b013e3283511b61, 22406480.
18. Cha SI, Chang CS, Kim EK, Lee JW, Matthay MA, Golden JA, et al. Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosis. Histopathology 2012, 61(1):98-106. 10.1111/j.1365-2559.2012.04197.x, 22394225.
19. Nagata N, Kitasato Y, Wakamatsu K, Kawabata M, Fukushima K, Kajiki A, et al. Prognostic value of immunohistochemical surfactant protein A expression in regenerative/hyperplastic alveolar epithelial cells in idiopathic interstitial pneumonias. Diagn Pathol. 2011, 6:25. 10.1186/1746-1596-6-25, 21435274.
20. Myllärniemi M, Vuorinen K, Pulkkinen V, Kankaanranta H, Aine T, Salmenkivi K, et al. Gremlin localization and expression levels partially differentiate idiopathic interstitial pneumonia severity and subtype. J Pathol 2008, 214(4):456-63. 10.1002/path.2300, 18072275.
21. Parra ER, Kairalla RA, de Carvalho CR R, Eher E, Capelozzi VL. Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia. Respiration 2007, 74(2):159-69. 10.1159/000097133, 17108669.
22. Daniil Z, Kitsanta P, Kapotsis G, Mathioudaki M, Kollintza A, Karatza M, et al. CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis. Respir Res. 2005, 6:81. 10.1186/1465-9921-6-81, 16042790.
23. Tsukamoto K, Hayakawa H, Sato A, Chida K, Nakamura H, Miura K. Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis. Thorax 2000, 55(11):958-61. 10.1136/thorax.55.11.958, 11050267.
24. Kaarteenaho-Wiik R, Tani T, Sormunen R, Soini Y, Virtanen I, Pääkkö P. Tenascin immunoreactivity as a prognostic marker in usual interstitial pneumonia. Am J Respir Crit Care Med 1996, 154(2 Pt 1):511-8. 10.1164/ajrccm.154.2.8756830, 8756830.
25. Cipriani NA, Strek M, Noth I, Gordon IO, Charbeneau J, Krishnan JA, et al. Pathologic quantification of connective tissue disease-associated versus idiopathic usual interstitial pneumonia. Arch Pathol Lab Med 2012, 136(10):1253-8. 10.5858/arpa.2012-0102-OA, 23020731.
26. Yoshinouchi T, Naniwa T, Shimizu S, Ohtsuki Y, Fujita J, Sato S, et al. Expression of chemokine receptors CXCR3 and CCR4 in lymphocytes of idiopathic nonspecific interstitial pneumonia. Respir Med 2007, 101(6):1258-64. 10.1016/j.rmed.2006.10.019, 17137778.
27. Terasaki Y, Fukuda Y, Suga M, Ikeguchi N, Takeya M. Epimorphin expression in interstitial pneumonia. Respir Res 2005, 6(1):6. 10.1186/1465-9921-6-6, 15651999.
28. Nakashima N, Kuwano K, Maeyama T, Hagimoto N, Yoshimi M, Hamada N, et al. The p53-Mdm2 association in epithelial cells in idiopathic pulmonary fibrosis and non-specific interstitial pneumonia. J Clin Pathol 2005, 58(6):583-9. 10.1136/jcp.2004.022632, 15917407.
29. Suga M, Iyonaga K, Okamoto T, Gushima Y, Miyakawa H, Akaike T, et al. Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2000, 162(5):1949-56. 10.1164/ajrccm.162.5.9906096, 11069839.
30. Zuo F, Kaminski N, Eugui E, Allard J, Yakhini Z, Ben-Dor A, et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci U S A 2002, 99(9):6292-7. 10.1073/pnas.092134099, 11983918.
31. Selman M, Pardo A, Barrera L, Estrada A, Watson SR, Wilson K, et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med 2006, 173(2):188-98. 10.1164/rccm.200504-644OC, 16166619.
32. Yang IV, Burch LH, Steele MP, Savov JD, Hollingsworth JW, McElvania-Tekippe E, et al. Gene expression profiling of familial and sporadic interstitial pneumonia. Am J Respir Crit Care Med 2007, 175(1):45-54. 10.1164/rccm.200601-062OC, 16998095.
33. Konishi K, Gibson KF, Lindell KO, Richards TJ, Zhang Y, Dhir R, et al. Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009, 180(2):167-75. 10.1164/rccm.200810-1596OC, 19363140.
34. Boon K, Bailey NW, Yang J, Steel MP, Groshong S, Kervitsky D, et al. Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis. PLoS One 2009, 4(4):e5134. 10.1371/journal.pone.0005134, 19347046.
35. Yang IV, Coldren CD, Leach SM, Seibold MA, Murphy E, Lin J, et al. Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis. Thorax 2013, 68(12):1114-21. 10.1136/thoraxjnl-2012-202943, 23783374.
36. Korfei M, Schmitt S, Ruppert C, Henneke I, Markart P, Loeh B, et al. Comparative proteomic analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and lung transplant donor lungs. J Proteome Res 2011, 10(5):2185-205. 10.1021/pr1009355, 21319792.
37. Korfei M, von der Beck D, Henneke I, Markart P, Ruppert C, Mahavadi P, et al. Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donors. J Proteomics. 2013, 85:109-28. 10.1016/j.jprot.2013.04.033, 23659799.
38. Patel NM, Kawut SM, Jelic S, Arcasoy SM, Lederer DJ, Borczuk AC. Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosis. Eur Respir J 2013, 41(6):1324-30. 10.1183/09031936.0084112, 23728404.
39. DePianto DJ, Chandriani S, Abbas AR, Jia G, N'Diaye EN, Caplazi P, et al. Heterogeneous gene expression signature correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis. Thorax 2015, 70:48-56. doi: 10.1136/thoraxjnl-2013-204596, 10.1136/thoraxjnl-2013-204596, 25217476.
40. Yang IV, Pedersen BS, Rabinovich E, Hennessy CE, Davidson EJ, Murphy E, et al. Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2014, 190(11):1263-72. 10.1164/rccm.201408-1452OC, 25333685.
41. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011, 183(6):788-824. 10.1164/rccm.2009-040GL, 21471066.
42. Blackwell TS, Tager AM, Borok Z, Moore BB, Schwartz DA, Anstrom KJ, et al. Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. Am J Respir Crit Care Med 2014, 189(2):214-22. 10.1164/rccm.201306-1141WS, 24160862.
43. Barkauskas CE, Noble PW. Cellular mechanisms of tissue fibrosis. 7. New insight into cellular mechanisms of pulmonary fibrosis. Am J Physiol Cell Physiol 2014, 306:C987-96. 10.1152/ajpcell.00321.2013, 24740535.
44. King TE, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011, 378(9807):1949-61. 10.1016/S0140-6736(11)60052-4, 21719092.
45. Ley B, Brown KK, Collard HR. Molecular biomarkers in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2014, 307:L681-91. 10.1152/ajplung.00014.2014, 25260757.
46. Kolb M, Collard HR. Staging of idiopathic pulmonary fibrosis: past, present and future. Eur Respir Rev 2014, 23(132):220-4. 10.1183/09059180.00002114, 24881076.